![]() |
市場調查報告書
商品編碼
1426961
骨骼和關節保健補充劑市場規模 - 按產品(維生素和礦物質、膠原蛋白)、形式(膠囊和片劑、粉末)、消費者(老年人、成人、孕婦)、配銷通路(藥房、電子商務)和全球預測(2024-2032)Bone & Joint Health Supplements Market Size - By Product (Vitamin & Minerals, Collagen), Form (Capsule & Tablets, Powders), Consumer (Geriatric, Adults, Pregnant Women), Distribution Channel (Pharmacies, E-commerce), & Global Forecast (2024-2032) |
在人口老化的推動下,骨關節保健品產業預計從 2024 年到 2032 年將以 7.5% 的CAGR成長。骨質疏鬆症和關節炎等骨骼和關節相關問題的盛行率不斷上升。根據《柳葉刀》的研究,預計到2050 年,全球約有10 億人患有骨關節炎,而根據《柳葉刀風濕病學》雜誌的數據,到2023 年,全球30 歲或以上人口中約有15% 患有骨關節炎。
人們擴大採取積極主動的措施來支持他們的整體健康,包括使用促進骨骼和關節健康的補充劑。隨著健身趨勢的不斷發展以及對保持積極生活方式的關注,消費者正在尋求含有鈣、維生素 D 和 omega-3 脂肪酸等關鍵成分的產品,以增強骨骼強度和靈活性。
整個骨關節保健品產業根據產品、形式、消費者、配銷通路和地區進行細分。
Omega-3 脂肪酸部分預計到 2032 年將大幅成長,因為它們具有抗發炎特性,可以緩解關節疼痛。魚油中含有的這些必需脂肪酸有助於維持最佳骨密度。消費者越來越重視自然的醫療保健方法,有利於該細分市場的成長。
由於生物利用度,預計粉末細分市場在 2023 年和 2032 年將出現顯著的CAGR。與傳統的藥丸或膠囊不同,粉末狀補充劑可以快速吸收,使身體能夠利用必需的營養素。此外,粉末形式在劑量客製化方面提供了更大的靈活性,使消費者能夠根據個人需求輕鬆調整攝取量。
受阿育吠陀和傳統中醫等傳統療法的青睞,亞太地區骨關節保健品市佔率將在 2023 年至 2032 年間大幅成長。在印度和中國等國家,久坐的生活方式和城市化日益盛行,導致肌肉骨骼問題的發生率增加,從而產生了對解決這些問題的補充劑的需求。採用創新配方,將古老方法與現代營養科學結合,進一步刺激了區域產業的成長。
Bone & Joint Health Supplements Industry is projected to grow at a CAGR of 7.5% from 2024 to 2032, driven by aging population. There is a rising prevalence of bone and joint-related issues, such as osteoporosis and arthritis. According to Lancet study, around one billion people globally are estimated to suffer from osteoarthritis by 2050, and as per the Lancet Rheumatology journal, around 15% of the global population aged 30 years or above had osteoarthritis in 2023.
People are increasingly adopting proactive measures to support their overall well-being, including the use of supplements that promote bone and joint health. With growing fitness trends and a focus on maintaining an active lifestyle, consumers are seeking products containing key ingredients such as calcium, vitamin D, and omega-3 fatty acids to enhance bone strength and flexibility.
The overall bone & joint health supplements industry is segmented on the basis of product, form, consumer, distribution channel, and region.
Omega-3 fatty acid segment is anticipated to witness substantial growth through 2032, as they exhibit anti-inflammatory properties that can alleviate joint pain. These essential fatty acids, found in fish oil, help in maintaining optimal bone density. The consumers are increasingly prioritizing natural approaches to healthcare, favoring the segment growth.
Powder segment is expected to observe a significant CAGR during 2023 and 2032, attributed to the bioavailability. Unlike traditional pills or capsules, powdered supplements can be quickly absorbed, allowing the body to utilize the essential nutrients. Additionally, the powder format provides greater flexibility in dosage customization, enabling consumers to easily adjust their intake based on individual needs.
Asia Pacific bone & joint health supplements market share will grow substantially between 2023 and 2032, favored by the emphasis on traditional practices such as ayurveda and traditional chinese medicine. The rising prevalence of sedentary lifestyle and urbanization in countries such as India and China has resulted in an increased rate of musculoskeletal issues, creating a demand for supplements that address these concerns. The adoption of innovative formulations, blending ancient methods with modern nutritional science, further stimulates the regional industry growth.